Metformin og obstetriske patienter

Katrine Dahl Pedersen; Nathalie Søderhamn Bülow; Kasper Aaboe; Julie Galsgaard; Helle Sand Odgaard; Elisabeth Reinhardt Mathiesen; Jeannet Lauenborg

Metformin og obstetriske patienter

Katrine Dahl Pedersen, Nathalie Søderhamn Bülow, Kasper Aaboe, Julie Galsgaard, Helle Sand Odgaard, Elisabeth Reinhardt Mathiesen, Jeannet Lauenborg

Publikation: Bidrag til tidsskrift › Review › Forskning › peer review

Abstract

Polycystic ovary syndrome (PCOS) is associated with insulin resistance, infertility, obesity and gestational complications. Metformin is widely used in fertility treatment of women with PCOS, due to a suggested positive effect of continued metformin treatment beyond the first trimester on pregnancy complications. Larger randomized trials have failed to confirm this. Metformin treatment has not been found to be superior to insulin treatment in women with gestational diabetes and may be associated with long-term consequences in the children in the form of overweight and disturbed glucose metabolism.

Bidragets oversatte titel	Metformin and the obstetric patient
Originalsprog	Dansk
Artikelnummer	V05150438
Sider (fra-til)	1420-1423
Antal sider	4
Tidsskrift	Ugeskrift for laeger
Vol/bind	178
Udgave nummer	15
Tidlig onlinedato	7 dec. 2015
Status	Udgivet - 25 jul. 2016

Emneord

Breast Feeding
Diabetes, Gestational/drug therapy
Female
Humans
Hypoglycemic Agents/adverse effects
Metformin/adverse effects
Polycystic Ovary Syndrome/drug therapy
Pregnancy
Pregnancy Trimester, Second
Pregnancy Trimester, Third
Prenatal Exposure Delayed Effects

Citationsformater

@article{1ca0d80ced9246d1bbdb60bea56f832c,

title = "Metformin og obstetriske patienter",

abstract = "Polycystic ovary syndrome (PCOS) is associated with insulin resistance, infertility, obesity and gestational complications. Metformin is widely used in fertility treatment of women with PCOS, due to a suggested positive effect of continued metformin treatment beyond the first trimester on pregnancy complications. Larger randomized trials have failed to confirm this. Metformin treatment has not been found to be superior to insulin treatment in women with gestational diabetes and may be associated with long-term consequences in the children in the form of overweight and disturbed glucose metabolism. ",

keywords = "Breast Feeding, Diabetes, Gestational/drug therapy, Female, Humans, Hypoglycemic Agents/adverse effects, Metformin/adverse effects, Polycystic Ovary Syndrome/drug therapy, Pregnancy, Pregnancy Trimester, Second, Pregnancy Trimester, Third, Prenatal Exposure Delayed Effects",

author = "Pedersen, {Katrine Dahl} and B{\"u}low, {Nathalie S{\o}derhamn} and Kasper Aaboe and Julie Galsgaard and Odgaard, {Helle Sand} and Mathiesen, {Elisabeth Reinhardt} and Jeannet Lauenborg",

year = "2016",

month = jul,

day = "25",

language = "Dansk",

volume = "178",

pages = "1420--1423",

journal = "Ugeskrift for laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "15",

}

TY - JOUR

T1 - Metformin og obstetriske patienter

AU - Pedersen, Katrine Dahl

AU - Bülow, Nathalie Søderhamn

AU - Aaboe, Kasper

AU - Galsgaard, Julie

AU - Odgaard, Helle Sand

AU - Mathiesen, Elisabeth Reinhardt

AU - Lauenborg, Jeannet

PY - 2016/7/25

Y1 - 2016/7/25

N2 - Polycystic ovary syndrome (PCOS) is associated with insulin resistance, infertility, obesity and gestational complications. Metformin is widely used in fertility treatment of women with PCOS, due to a suggested positive effect of continued metformin treatment beyond the first trimester on pregnancy complications. Larger randomized trials have failed to confirm this. Metformin treatment has not been found to be superior to insulin treatment in women with gestational diabetes and may be associated with long-term consequences in the children in the form of overweight and disturbed glucose metabolism.

AB - Polycystic ovary syndrome (PCOS) is associated with insulin resistance, infertility, obesity and gestational complications. Metformin is widely used in fertility treatment of women with PCOS, due to a suggested positive effect of continued metformin treatment beyond the first trimester on pregnancy complications. Larger randomized trials have failed to confirm this. Metformin treatment has not been found to be superior to insulin treatment in women with gestational diabetes and may be associated with long-term consequences in the children in the form of overweight and disturbed glucose metabolism.

KW - Breast Feeding

KW - Diabetes, Gestational/drug therapy

KW - Female

KW - Humans

KW - Hypoglycemic Agents/adverse effects

KW - Metformin/adverse effects

KW - Polycystic Ovary Syndrome/drug therapy

KW - Pregnancy

KW - Pregnancy Trimester, Second

KW - Pregnancy Trimester, Third

KW - Prenatal Exposure Delayed Effects

M3 - Review

C2 - 26651913

SN - 0041-5782

VL - 178

SP - 1420

EP - 1423

JO - Ugeskrift for laeger

JF - Ugeskrift for laeger

IS - 15

M1 - V05150438

ER -

Metformin og obstetriske patienter

Abstract

Emneord

Fingeraftryk

Citationsformater